Signal detail

TOI The Oncology Institute, Inc.

Updated 7:27 AMMarket data as of Jul 10, 2026

Bullish alignedEvidence coverage: HighHorizon: 20 trading days

Bullish evidence is led by Estimates, Price Targets, and Technical.

Main positive: Estimate revisions
Main negative: No clear negative blocker
Watch next: Estimate stabilization

Price-model views unavailable in this refresh. Price-model filters are disabled until the next matching artifact publishes.

Price Model / Risk

Why this model viewPrice call unavailable.

Key levelNo call — evidence only

Model thesisAwait latest price-call artifact.

Benchmarkn/a

Signal supportNo matching price-call artifact row.

Returns

5D10D20D

Stockn/an/an/a

Benchmarkn/an/an/a

Relativen/a

Price levels

Closen/a

Pullback lown/a

Supportn/a

Resistancen/a

SMA20n/a

SMA50n/a

Drivers

None

Warnings

None

Research / Monitor

Quality context

C qualityQuality-supported bull

Quality data supports research context and still needs signal confirmation.

Analyst / Fundamentals

FundamentalsDebt ok

Analyst coverage3 analysts / 20%+ upside

FlagsLeverage ok + Analyst covered

Monitor

WatchEstimate stabilization

Newsmarkets

HistoryNo measured history yet

Freshness

Fundamentals week2026-W28

Analyst dateJul 10, 2026

Price-model track record

TOI’s past model calls

This symbol’s completed bullish and bearish model views from the last 120 trading days, measured against their assigned benchmark after next trading-day entry.

Updated Jul 10, 2026

SIGNAL DATE	SYMBOL	MODEL VIEW	ENTRY DATE	ENTRY CLOSE	5D VS BENCH	10D VS BENCH	20D VS BENCH	STATUS
Jun 18, 2026	TOI The Oncology Institute, Inc.	Bearish View	Jun 22, 2026	$5.01	Missed — beat IWM by 11.5 pts	Missed — beat IWM by 16.4 pts	Pending	10D measured
Jun 17, 2026	TOI The Oncology Institute, Inc.	Bearish View	Jun 18, 2026	$5.26	Missed — beat IWM by 1.0 pts	Missed — beat IWM by 2.3 pts	Pending	10D measured
Jun 16, 2026	TOI The Oncology Institute, Inc.	Bearish View	Jun 17, 2026	$5.25	Worked — lagged IWM by 5.6 pts	Worked — lagged IWM by 2.1 pts	Pending	10D measured
Jun 15, 2026	TOI The Oncology Institute, Inc.	Bearish View	Jun 16, 2026	$5.10	Missed — beat IWM by 1.4 pts	Missed — beat IWM by 5.6 pts	Pending	10D measured
Jun 12, 2026	TOI The Oncology Institute, Inc.	Bearish View	Jun 15, 2026	$5.18	Worked — lagged IWM by 2.6 pts	Missed — beat IWM by 2.9 pts	Pending	10D measured
Jun 8, 2026	TOI The Oncology Institute, Inc.	Bearish View	Jun 9, 2026	$4.96	Missed — beat IWM by 1.8 pts	Missed — beat IWM by 3.2 pts	Pending	10D measured
Jun 4, 2026	TOI The Oncology Institute, Inc.	Bearish View	Jun 5, 2026	$4.87	Missed — beat IWM by 6.8 pts	Worked — lagged IWM by 1.2 pts	Missed — beat IWM by 15.7 pts	Matured
Jun 2, 2026	TOI The Oncology Institute, Inc.	Bearish View	Jun 3, 2026	$4.23	Missed — beat IWM by 12.8 pts	Missed — beat IWM by 23.6 pts	Missed — beat IWM by 21.6 pts	Matured
Jun 1, 2026	TOI The Oncology Institute, Inc.	Bearish View	Jun 2, 2026	$4.59	Missed — beat IWM by 9.0 pts	Missed — beat IWM by 11.0 pts	Missed — beat IWM by 17.4 pts	Matured
May 28, 2026	TOI The Oncology Institute, Inc.	Bearish View	May 29, 2026	$4.69	Missed — beat IWM by 5.2 pts	Missed — beat IWM by 12.4 pts	Missed — beat IWM by 16.5 pts	Matured
May 27, 2026	TOI The Oncology Institute, Inc.	Bearish View	May 28, 2026	$4.71	Missed — beat IWM by 0.6 pts	Missed — beat IWM by 9.5 pts	Missed — beat IWM by 11.8 pts	Matured

Evidence

Signal rows

Evidence	Signal	Strength	What changed	Impact
	BullishFirst seen 3 sessions ago	High	Largest current-year revision is +8.0%	Main positive driver
Why this matters Estimate revisions show whether earnings and revenue expectations are moving in a helpful or harmful direction. MarketMind interpretation Largest current-year revision is +8.0% MarketMind currently classifies TOI as Bullish aligned. Source detail EPS revision +8.0% Revenue revision -0.4% EPS analysts 3 Revenue analysts 3 Date Jul 10, 2026
	Neutral	Low	No threshold-level insider activity in the current window	Monitor only
Why this matters Insider activity can flag whether company insiders are buying into the setup or selling into strength. MarketMind interpretation No threshold-level insider activity in the current window MarketMind currently classifies TOI as Bullish aligned. Source detail Net insider value $27,428.22 Buy count 6 Sell count 3 Last trade BUY Last title 10 Percent Owner Date Jun 23, 2026
	BullishFirst seen 1 session ago	High	breakout detected	Supportive evidence
Why this matters Technical action shows whether price and volume confirm the setup or create timing risk. MarketMind interpretation breakout detected MarketMind currently classifies TOI as Bullish aligned. Source detail 1d return +0.7% 20d return +10.9% Gap 0.0% Date Jul 10, 2026
	Context	Low	Earnings expected in 33 calendar days	Monitor only
Why this matters Earnings reaction shows whether the market rewarded or rejected the most recent company update. MarketMind interpretation Earnings expected in 33 calendar days MarketMind currently classifies TOI as Bullish aligned. Source detail Earnings date Aug 12, 2026 Reaction +0.7%
	BullishFirst seen 3 sessions ago	High	Consensus target changed +11.1% week over week	Supportive, not decisive
Why this matters Price targets show whether analyst valuation expectations support or resist the current stock price. MarketMind interpretation Consensus target changed +11.1% week over week MarketMind currently classifies TOI as Bullish aligned. Source detail Target change +11.1% Upside +41.4% Analysts 3 Consensus target $8.33 Date Jul 10, 2026
	Context	Low	BTIG: Buy to Buy	Monitor only
Why this matters Analyst rating changes can show whether professional expectations are improving or deteriorating. MarketMind interpretation maintain MarketMind currently classifies TOI as Bullish aligned. Source detail Action maintain Firm BTIG Rating move Buy to Buy Date Jul 9, 2026
	Context	Low	markets	Monitor only
Why this matters News context explains whether current headlines are active enough to monitor, without treating raw coverage as a directional signal. MarketMind interpretation fading news context MarketMind currently classifies TOI as Bullish aligned. Source detail Source GlobeNewsWire Category markets Tier 1 Date Jul 7, 2026

Method & data

How each setup is built

Each row starts with rules-based signal detection, then checks which evidence lanes are active, whether price action and benchmark context pass the current rule gates, and what level would confirm or invalidate the setup.

Price-model views return after the next matching artifact refreshes.Evidence: shows which bullish and bearish rule inputs are active.Price model: positive and neutral views come from long-entry gates; exit watch and negative views come from extension plus technical weakening.Price action: 5D/10D/20D shows benchmark-relative movement into the latest close, not a completed result.Expanded details show the raw stock move, benchmark move, and relative spread.Confirm / break: the level that would validate or invalidate the setup.Outcomes: completed price-model views appear separately after the measurement window matures.

	SYMBOL	SETUP	SIGNAL CLOSE	EVIDENCE SUPPORT	TOP FACTORS	RULE CONF.	5D	10D	20D	VS BENCH	CONFIRM / BREAK	WHY	DETAILS

Signals

Explore

TOI The Oncology Institute, Inc.

TOI’s past model calls

Signal rows

Why this matters

MarketMind interpretation

Source detail

Why this matters

MarketMind interpretation

Source detail

Why this matters

MarketMind interpretation

Source detail

Why this matters

MarketMind interpretation

Source detail

Why this matters

MarketMind interpretation

Source detail

Why this matters

MarketMind interpretation

Source detail

Why this matters

MarketMind interpretation

Source detail